Senate delays Cures bill, as window for major legislation narrows
(By David Nather for STAT) WASHINGTON — Lawmakers are officially giving up hopes of considering a bill to speed the development of
Read More
Legislative Update
FDA narrowly defines the ability of compounders to make approved medicines
(By Ed Silverman for STAT) In its latest to bid to set parameters around compounding, the US Food and Drug
Read MoreHouse Panel Extends Funding For Medicare Program To Help Consumers
(By Susan Jaffe for Kaiser Health News) A House subcommittee voted on Thursday to continue $52 million in funding for
Read MoreH.R. 2646 Passed the House
On Wednesday, the House overwhelmingly passed bill H.R. 2646: Helping Families in Mental Health Crisis Act of 2015. Read article
Read MoreHHS announces new actions to combat opioid epidemic
(Source – www.hhs.gov) U.S. Health and Human Services (HHS) Secretary Sylvia M. Burwell today announced several new actions the department
Read More5 Myths About FDA’s Regulation of Vapor Products
(By Elaine Keller for The Daily Signal) On May 5, the U.S. Food and Drug Administration finalized a rule known
Read MoreThe Federal Court Appeals Decision Will Cost You
On Tuesday, a federal appeals court ruled that biosimilar drug makers must always notify their brand-name rivals six months before
Read MoreThe New Oncology Care Model
On July 1st, the Centers of Medicare and Medicaid (CMS) launched the new five year Oncology Care Model aimed at
Read MoreNew Guidelines not Regulation for Conflict of Interest
The US Food and Drug Administration have issued a draft guidance spelling out circumstances when the appearance of a conflict
Read MoreHHS Announces Physician Groups Selected for an Initiative Promoting Better Cancer Care
(Source – www.hhs.gov) HHS Oncology Care Model attracts almost twice the expected number of physician group practices The U.S. Department
Read More